Microfactory has just completed the first part of its in vivo/in vitro correlation on antiperspirant efficiency evaluations.

The SOD4 technology characterised the efficacy of 5 antiperspirants in a single blind study. In association with a Parisian CRO, these predictions were confirmed by gravimetry, the current method of in vivo testing.

Our technology measures the pressure required to expel the clots formed during the sweat/antiperspirant contact in the microfluidic synthetic pores.

The results of the in vivo and in vitro tests are consistent, SOD4 represents a predictive and economical alternative to human antiperspirant efficacy evaluations.

 

Read the complete article: ZOOM#17 -Testing trends nails evaluation – in vitro efficacy testing – Skinobs.web

Contact

Fabrice Monti, PhD

www.microfactory.eu

11 rue Vauquelin Angle Rue Lagarde/Rue Vauquelin

75005  Paris

Tél: + 33 (0) 6 62 72 04 61

Recent Posts

Skinobs revamps We Are Testing® with a bold new identity

Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…

We Are Testing® at NYSCC Suppliers’ Day 2025

👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…

Pollution, a relevant exposome factor in skin aging and the role of multi-benefit photoprotection via ACTAS

J. Santamaria, Y. Gilaberte, L. Prudkin, J. Piquero-Casals 11 March 2025 Skin aging is a…